These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6119644)

  • 1. [3H]Sulpiride, a ligand for neuroleptic receptors.
    Freedman SB; Poat JA; Woodruff GN
    Neuropharmacology; 1981 Dec; 20(12B):1323-6. PubMed ID: 6119644
    [No Abstract]   [Full Text] [Related]  

  • 2. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.
    Leysen JE
    Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770
    [No Abstract]   [Full Text] [Related]  

  • 7. A serotonergic component of neuroleptic receptors.
    Leysen JE; Laduron PM
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):337-9. PubMed ID: 23731
    [No Abstract]   [Full Text] [Related]  

  • 8. The mode of action of sulpiride as an atypical antidepressant agent.
    Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 32():85-103. PubMed ID: 7046370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man.
    Szallasi A
    Acta Physiol Scand Suppl; 1995; 629():1-68. PubMed ID: 8801775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Profile of the adverse effects of neuroleptic drugs in relation to its receptor binding].
    Gerlach J
    Nord Med; 1987; 102(4):120-3. PubMed ID: 2884620
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
    Itokawa M; Toru M; Ito K; Tsuga H; Kameyama K; Haga T; Arinami T; Hamaguchi H
    Mol Pharmacol; 1996 Mar; 49(3):560-6. PubMed ID: 8643097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific receptors for substituted benzamide drugs in brain.
    Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1982; 35():109-41. PubMed ID: 6756059
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J; Christensen AV
    J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects.
    Svartengren J; Pettersson E; Björk A
    Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.